Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.

Cook, Peter J; Thomas, Rozario; Kannan, Ram; de Leon, Esther Sanchez; Drilon, Alexander; Rosenblum, Marc K; Scaltriti, Maurizio; Benezra, Robert et al. · Nat Commun · 2018

Where this comes from

Record sourced from PubMed, PMID 29532792.
Also identified by DOI 10.1038/ncomms16187 and PMC identifier 5857674.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

This corrects the article DOI: 10.1038/ncomms15987.

Read the full text

View on PubMed · Publisher (DOI)